Yes, Dr Welch has many millions of shares in addtion to

New Post Public Reply Private Reply Replies (2) Message Board
sunray3 sunclouds #154228
631

Yes, Dr Welch has many millions of shares in addtion to his 45 million in warrants, which he received to compensate him for the 6.5 million dollar surety bond for the Samsung deal that he backstopped. The man is widely viewed as a CytoDyn angel for having done that. He is an ardent CytoDyn supporter and would never sell his shares nor redeem his warrants (which have an exercise price of $0.10) in a way that would harm the company.

Just to clarify, the 30.6 warrant holders are actually in two groups:
..
Paulson Investment Co., llc holds warrants for 34 million shares, which they received as a placement fee for having brokered the sale of warrants to other investors not affiliated with Paulson. Paulson's cost for these warrants was zero. Most of these warrants have a strike of 0.306, but 3 millon are at a strike of 0.16 and Paulson may choose to exercise these at whatever price meets their goals, probably by shorting them against the warrants, which locks in gains, removes price risk and doesn't require buyback in the open market.

The other group (45 million warrants) consists of certified investors, small funds, etc..who hold warrants they've acquired via Paulson. These folks paid cash up front for their warrants and like us are longs with an interest in share price appreciation. I agree this non-Paulson affiliated $0.306 group isn't likely to exercise their warrants with the share price only a few cents above the strike as it is now, and they are longs with skin in the game like us...but it must be said they're a varied group, and when they are going to exercise depends on their goals, whether short or longer-term.

The Paulson-held shares are the ones wihich need to concern us, IMO. Their goals as warrant holders are not those of retail longs like us. While the argument is being made that only a relatively few cents profit is to be had, one must remember that Paulson's cost basis is zero, and that 0.05 (or more, they do have millions of warrants further in the money) is pure profit to them. They can short the stock at 0.35, then deliver the shares later via cashless exercise for 0.306.or lower depending on the strike. No cash required, no open market buybacks. Done at scale (millions of shares) pennies add up.

Honestly, no one knows when Paulson will have exercised his warrants and fulfilled the above scenario. But his goals are different from ours as dedicated longs who are supportive of the company and wait for news to drive the share price...Paulson's goal is monetization, not appreciation, and it's when, not whether they will pursue this. They are likely to sell into strength, short against the warrants to lock in gains, and sell quickly without holding long term.

I'm not saying the sky is falling here, but I do think that it's silly not to be aware of how certain of these warrants can factor into the share price, at least for now. Not so long ago I was skeptical of this and was all-in blaming the shorts for all our SP troubles, but I've come to realize that Paulson is definitely in there as well, as some have beein saying.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Waters Acquires MOBILion: Ion Mobility Meets AI

Updated Category News Views 59

MOBILion Joins Waters' Fold: A New Era for Proteomics Ah, the biotech world just saw another big whirl with Waters Corporation snagging MOBILion Systems. Now, this isn't just some stroll in the market park. We're talking about weaving MOBILion's fancy high-resolution ion mobility separation tech right into Waters' already robust mass spectrometry setup. These folks are...

Continue Reading
Montefiore Einstein Takes On Breast Cancer's Hidden Battle

Updated Category News Views 11

Call me old-fashioned, but when cancer whispers in the shadows even after it's supposedly signed off the death certificate, you're dealing with one heck of a slippery adversary. That's where Montefiore Einstein Comprehensive Cancer Center comes in, armed with ten million greenbacks from the National Cancer Institute, primed to rattle the labyrinth of breast cancer...

Continue Reading
JLL Snaps Up Prime Boston Warehouse for $36M

Updated Category News Views 58

Diving Deep into JLL's Latest Acquisition If you blinked, you might have missed JLL Income Property Trust's latest power move. These folks just laid down $36 million for a prime 54,000-square-foot Class A distribution hub in Northborough, Massachusetts. This isn't just any run-of-the-mill facility; it's 100% leased to a heavy-hitting tenant for the next 14 years with neat...

Continue Reading
Sunrate's Bold Move: New Payment Bond with Netstorming

Updated Category News Views 18

Sunrate Joins Forces with Netstorming When two industry powerhouses shake hands, it's wise to sit up and listen. Sunrate, the global whiz in payment solutions, has linked arms with Netstorming, a tech-savvy pioneer in the travel sector. This ironclad partnership was announced at World Travel Market London 2026. Owners of travel businesses should take note: things are...

Continue Reading
MemorialCare Expands Cutting-Edge GERD Treatment Options

Updated Category News Views 182

Shifting the GERD Treatment Paradigm While everyone's talking about breakthrough technologies like AI and blockchain in medicine, MemorialCare seems to have quietly flipped the script on treating gastroesophageal reflux disease (GERD). They're sidestepping conventional maneuvers by embracing two procedures known as transoral incisionless fundoplication (TIF) and its...

Continue Reading
Mill Creek's Bold Move into Denver's Cherry Creek

Updated Category News Views 13

Taking a Stroll Down Cherry Creek The move by Mill Creek Residential into Cherry Creek North is a bold one, but they aren't exactly newcomers to this high-end neighborhood. They're planting their flag with the Modera Second Avenue, targeting Denver's upscale renters. With a Walk Score of 89, the location is a sweet spot for deep-pocketed folks who want the boutiques and...

Continue Reading
Midterms Stir Markets; Event Contracts Fuel Q3 Gains

Updated Category News Views 62

Midterms Mingle with Financial Markets Folks, throw those ballots into the ring, because today the midterms are kicking things off and boy, are they shaking up the game on these prediction markets. Traders and exchanges are on their toes, and the money's flowing like cold brew in July. Robinhood, Intercontinental Exchange, CME Group, and others reported noticeable ripples...

Continue Reading
Vanessa Hering's Empathetic Model Wins 2026 Herizon Award

Updated Category News Views 44

Recognizing a Game-Changer in Financial Wellness Vanessa Hering's name isn't just getting thrown around for no reason, folks. She's the client success officer at Beyond Finance, a heavyweight in the financial wellness arena, and she's just snagged the 2026 Herizon Award. This ain't some run-of-the-mill accolade; it acknowledges the profound changes she's spearheaded in...

Continue Reading
Jeep Wrangler Scrambler SRT: A Bold Off-Road Rebirth

Updated Category News Views 43

A New Legend in the Making Who would've thought we'd see the day when an SRT badge graced a Jeep Wrangler with such audacity? This ain't your typical Wrangler—they’ve slapped a bit of that CJ-8 throwback swagger, and given it the full-on SRT treatment. It's a mad machine, barreling into the future with one foot firmly planted in its legendary past. You ask any...

Continue Reading
Ravi Bhalla Snags Top Franchise Award with $5M Milestone

Updated Category News Views 7

From Local Fixture to National Recognition Ravi Bhalla, owner of PostalAnnex #16006 in Calabasas, CA, takes home the Crystal Award at Annex Brands' 2026 National Convention in Vegas. And let me tell you, this isn't just some shiny trophy to stuff in a display case. This is major. Shattering Sales Goals What's the big kerfuffle over? It's this: Bhalla cracked the $5...

Continue Reading

Top 5 Most Recently Viewed Articles

Dry Age-Related Macular Degeneration Market Growth Insights

Updated Category News Views 54

The Expansion of the Dry Age-Related Macular Degeneration Market The Dry Age-related Macular Degeneration (AMD) market is experiencing significant growth, with projections indicating an increase from USD 4.83 billion in recent years to an impressive USD 10.57 billion by the year 2032. This remarkable growth, anticipated at a compound annual growth rate (CAGR) of 9.1% from...

Continue Reading
Eli Lilly's Earnings Outlook: Focus on Game-Changing Drugs

Updated Category News Views 157

Eli Lilly's Earnings Outlook: A Critical Moment Eli Lilly & Co. (NYSE: LLY) is gearing up for its upcoming earnings report, an event that many investors will monitor closely. The pharmaceutical giant has recently solidified its dominance in the weight-loss drug sector with its newest offering, Zepbound, which currently holds an impressive 59% share of U.S. prescriptions....

Continue Reading
Dream Finders Homes Reports Strong Growth With New Acquisitions

Updated Category News Views 197

Dream Finders Homes' Third Quarter Performance Overview Dream Finders Homes, Inc. (NYSE: DFH) released its financial outcomes for the third quarter. The homebuilder showcased remarkable growth, with revenues reaching $986 million, up 10% compared to $894 million in the same quarter last year. Key Highlights from the Third Quarter 2024 Notable achievements include a 5%...

Continue Reading
CrowdStrike's SIEM Innovation Recognized in 2024 IDC MarketScape

Updated Category News Views 97

CrowdStrike's Recognition in the IDC MarketScape 2024 CrowdStrike (NASDAQ: CRWD) has achieved significant recognition for its contributions in the realm of cybersecurity, being named a Major Player in the IDC MarketScape's 2024 Worldwide Security Information and Event Management (SIEM) for Enterprise Vendor Assessment report. This assessment acknowledges CrowdStrike's...

Continue Reading
Innovative Therapeutic Chair Aimed at Enhancing Comfort

Updated Category News Views 305

Revolutionary Therapeutic Chair for Enhanced Comfort A new therapeutic chair has been developed to provide relief for those suffering from lower back pressure and pain. An inventor from Grayson identified the need for a chair that not only supports proper posture but also offers lumbar support, enhancing overall sitting experience. Features of the EVENT COMFORT CHAIR This...

Continue Reading